SAILIFE

Sai Life Sciences Ltd.

NSE: SAILIFE

BSE: 544306

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,247.40+9.4 (+0.76%)

3 Jul, 1:59 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

98.1 / 100

Value Score

6.0 / 100

Price Momentum Score

96.6 / 100

QVM Score

83.1 / 100

Key Metrics

Market Cap

26281.00

P/E (TTM)

75.32

P/B

10.58

P/S (TTM)

11.99

EV/EBITDA

41.68

CAPE (5Y)

207.71

ROE (TTM)

15.13

ROCE (TTM)

17.68

ROA (TTM)

10.28

Avg 3Y ROE

11.66

Earnings 3Y CAGR

224.62

Sales 3Y CAGR

21.67

Sales 5Y CAGR

Debt/Equity

0.12

Consensus TP

1274.00

Strong Buy %

60.00

Promoter Holding

34.61

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Sai Life Sciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 96.6 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

96.6 / 100

High and improving ROE

The company reported strong ROE of 15.13% for 12-month ended 31 Mar 2026 and ROE improved by 417 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 21.18% for 12-month ended 31 Mar 2026 and operating margin improved by 542 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 29.38% for 12-month ended 31 Mar 2026 and the growth was 18.14 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 29.38

-82.35114662

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 90.83% for 12-month ended 31 Mar 2026 and the growth was 82.71 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.12 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.05 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 72.4 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

72.4 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 75.32 indicates that the stock is expensive on a standalone basis and is at a 148.91% premium to industry median P/E

What is P/E Ratio?

Median: 30.26

Value 75.32

-215.443183

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -2.62% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Not enough data

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Sai Life Sciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Sai Life Sciences Ltd. Shareholding Pattern

Quarterly breakdown of Sai Life Sciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Aug 2013	Sep 2014	Sep 2015	Aug 2016	Aug 2017	Sep 2018	Sep 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	42.38	42.96	43.79	40.24	40.35	39.79	34.46	34.43	38.21	37.95	37.91	35.24	35.24	35.17	35.15	34.94	34.70	34.61
Indian Promoter	5.82	5.92	21.51	33.31	33.42	32.95	28.54	32.32	36.23	35.98	35.96	33.55	33.55	33.48	33.46	33.27	33.03	32.95
Foreign Promoter	36.56	37.04	22.27	6.93	6.93	6.84	5.92	2.11	1.98	1.97	1.95	1.69	1.69	1.69	1.69	1.68	1.67	1.66
Institutions	0.00	0.00	0.00	28.42	28.42	0.00	0.00	0.00	6.06	6.01	5.99	13.24	23.67	25.62	36.22	52.41	52.81	52.71
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.24	10.19	11.54	18.73	26.17	27.57	27.80
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.26	1.41	1.31	2.50	3.15	3.24	3.07
Govt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	28.42	28.42	0.00	0.00	0.00	6.06	6.01	5.99	7.63	11.72	12.36	14.57	22.50	21.41	21.17
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.35	0.41	0.41	0.60	0.60	0.67
Non-Institution	57.62	57.04	56.21	31.34	31.23	60.21	65.54	65.57	55.73	56.04	56.10	51.52	41.09	39.21	28.64	12.65	12.49	12.68
Bodies Corporate	0.00	0.00	33.18	18.54	18.54	17.93	0.00	0.00	0.00	0.00	0.00	0.30	0.87	0.31	0.30	0.43	0.35	0.47
Others (incl. Retail) No. of shareholders	57.62 0	57.04 0	23.03 0	12.80 0	12.69 0	42.28 0	65.54 0	65.57 0	55.73 0	56.04 0	56.10 0	51.22 5,72,396	40.22 1,80,822	38.90 1,40,452	28.34 1,26,129	12.22 1,19,257	12.14 1,14,355	12.21 1,16,987

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Smallcap 50	2.22%	20 / 49
2	Nifty Smallcap 250	0.8%	25 / 249
3	Nifty 500	0.08%	220 / 499
4	Nifty Total Market	0.08%	223 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sai Life Sciences Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Tuneer Ghosh Designated Person	February-2025	Market Sale (Disposal) 26th Feb 2025	0.28 %	₹ 356.54	2.84 lac	₹ 10.14 cr
Rajesh V Naik Designated Person	January-2025	Market Sale (Disposal) 2nd Jan 2025	0.10 %	₹ 730.00	1.50 lac	₹ 10.95 cr
Supratim Halder Designated Person	January-2025	Market Sale (Disposal) 2nd Jan 2025	0.00 %	₹ 740.69	2.00 k	₹ 14.81 lac
Alagappan Subramanian Designated Person	December-2024	Market Sale (Disposal) 27th Dec 2024	0.00 %	₹ 717.50	2.00 k	₹ 14.35 lac

No corporate action data available.

Company Profile

Overview of Sai Life Sciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Sai Life Sciences Limited is an India-based company. The Company is a contract research, development, and manufacturing organization (CRDMO). It offers a range of tailor-made services for biotech firms or global pharma company requirements. Its services include integrated drug discovery services, dr...

Key personnel

Ms. Runa Karan

Chief Compliance Officer, Company Secretary

Mr. Kanumuri Ranga RajuD

Executive Chairman of the Board

Mr. Krishnam Raju KanumuriD

Chief Executive Officer, Managing Director

Mr. Sivaramakrishnan ChittorD

Additional Whole-Time Director and Chief Financial Officer

Mr. Ramesh Ganesh IyerD

Independent Director

Dr. Dinesh V. Patel, Ph.D.D

Additional Independent Director

Ms. Suchita SharmaD

Independent Director

Mr. Rajagopal Srirama TattaD

Independent Director

Incorporated on

25 Jan 1999

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

18 Dec 2024

Free Float

13,16,97,737

Website

https://www.sailife.com/

Phone no.

+914068156000

Address

L4- 01 & 02, SLN, Terminus Survey, Survey no. 133,Gachibowli Miyapur, Gachibowli, HYDERABAD, 500032, India

Frequently Asked Questions

What is the current share price of Sai Life Sciences Ltd.?

The current share price of Sai Life Sciences Ltd. is ₹ 1,247.40 as of 3 Jul 2026.

What is the market capitalisation of Sai Life Sciences Ltd.?

The market capitalisation of Sai Life Sciences Ltd. stands at ₹ 26,281.00 Cr.

What is the PE ratio of Sai Life Sciences Ltd.?

The Price-to-Earnings (PE) ratio of Sai Life Sciences Ltd. is 75.32 as of the latest trailing twelve months data.

What is the ROE and ROCE of Sai Life Sciences Ltd.?

Sai Life Sciences Ltd. has a Return on Equity (ROE) of 15.13% and a Return on Capital Employed (ROCE) of 17.68% as per the latest financial reports.

What is the 52-week high and low of Sai Life Sciences Ltd.?

The 52-week high of Sai Life Sciences Ltd. is - and the 52-week low is -.

What is the dividend yield of Sai Life Sciences Ltd.?

The dividend yield of Sai Life Sciences Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Sai Life Sciences Ltd.?

Foreign Institutional Investors (FII) hold 21.17%, Domestic Institutional Investors (DII) hold 30.87% and retail/public investors hold 12.21% of Sai Life Sciences Ltd. shares.

What sector does Sai Life Sciences Ltd. belong to?

Sai Life Sciences Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Sai Life Sciences Ltd. with a consensus target price of ₹ 1,274.00, implying 2.91% upside from current levels.

What is the beta of Sai Life Sciences Ltd.?

The beta of Sai Life Sciences Ltd. is 0.86, indicating its price volatility relative to the broader market. Over the past 1 year, Sai Life Sciences Ltd. has delivered an absolute return of 65.75%.

What is the RSI of Sai Life Sciences Ltd.?

The 14-day Relative Strength Index (RSI) of Sai Life Sciences Ltd. is 61.27, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Sai Life Sciences Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Sai Life Sciences Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Company Profile

Holdings and Presence

Stock Analysis